Figure 3 | Scientific Reports

Figure 3

From: SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study

Figure 3

Receiver operating characteristic curves and areas under the curve depicting the diagnostic accuracy of suPAR, SOFA score, SAPS II, and all three combined for 90-day mortality in NSTI patients. SuPAR ROC-AUC: 0.77 (95% CI, 0.7–0.85), SAPS II ROC-AUC: 0.86 (95% CI, 0.91–0.92), SOFA score ROC-AUC: 0.82 (95% CI, 0.74–0.9), SAPS II + suPAR + SOFA score ROC-AUC: 0.87 (95% CI, 0.81–0.92), SuPAR, soluble urokinase-type plasminogen activator receptor; SOFA, Sequential Organ Failure Assessments; SAPS II, Simplified Acute Physiological Score II; NSTI, necrotizing soft tissue infections.

Back to article page